Braulke T, Causin C, Waheed A, Junghans U, Hasilik A, Maly P, Humbel R E, von Figura K
Biochemie II, Georg-August-Universität, Göttingen, West Germany.
Biochem Biophys Res Commun. 1988 Feb 15;150(3):1287-93. doi: 10.1016/0006-291x(88)90769-3.
Pentamannosyl phosphate substituted bovine serum albumin (PMP-BSA) and insulin like growth factor II (IGF II) bind specifically to immobilized mannose 6-phosphate/insulin like growth factor II receptor. An excess of IGF II inhibited binding of PMP-BSA by less than or equal to 20%, and an excess of PMP-BSA inhibited binding of IGF II by less than or equal to 10%. Polyclonal antibodies against the receptor purified from human liver inhibited preferentially the binding of PMP-BSA, and a monocloncal antibody 2C2 inhibited only the binding of IGF II to the receptor. Similar results were obtained for binding of PMP-BSA and IGF II to human skin fibroblasts. These results suggest that the binding sites for mannose 6-phosphate and IGF II reside in different portions of the receptor.
磷酸五甘露糖基取代的牛血清白蛋白(PMP - BSA)和胰岛素样生长因子II(IGF II)特异性结合固定化的甘露糖6 - 磷酸/胰岛素样生长因子II受体。过量的IGF II对PMP - BSA结合的抑制作用小于或等于20%,过量的PMP - BSA对IGF II结合的抑制作用小于或等于10%。从人肝脏纯化的针对该受体的多克隆抗体优先抑制PMP - BSA的结合,而单克隆抗体2C2仅抑制IGF II与该受体的结合。PMP - BSA和IGF II与人皮肤成纤维细胞的结合也得到了类似结果。这些结果表明,甘露糖6 - 磷酸和IGF II的结合位点位于受体的不同部位。